Chronic Hepatitis B infection clincal trials now open
What is hepatitis B infection?
Hepatitis B is a hepatotrophic virus that infect the liver cells.
Hepatitis B is a hepatotrophic virus that infect the liver cells.
The virus can be transmitted through blood transfusions with infected blood products, needle prick injuries, sexual intercourse, sharing needles during intravenous drug abuse and vertical transmission from mother to child.
How infectious is the hepatitis B virus?
The virus is 100 times more infectious then HIV.
Does everyone develop Chronic hepatitis B after being infected by the virus?
No, approximately 10% of patients infected by the virus develop chronic hepatitis or become asymptomatic carriers of the virus.
What is the spectrum of disease in chronic hepatitis B infection?
CHB infection gives a diverse spectrum of disease from a low viraemic immune control state to chronic hepatitis that can cause cirrhosis of the liver, liver failure and hepatocellular carcinoma.
What treatment is available for CHB infection?
Interferon-based therapies and Nucleoside/Nucleotide therapies are available.
Do the available therapies cure CHB infection?
No, the HBV infection cannot be eradicated with the current available therapies.
Are there current clinical trials with new treatment for CHB infection?
Yes, there are clinical trials available that are enrolling in South Africa and other parts of the world.
Register Here
Register here and you will be contacted by the research team.
